
Decipher Labs Ltd Stock Falls to 52-Week Low of Rs.5.84
2026-03-04 11:08:37Decipher Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.5.84 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions.
Read full news article
Decipher Labs Ltd Falls to 52-Week Low Amid Continued Financial Struggles
2026-03-02 11:43:02Decipher Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.5.93 today, marking a significant decline amid ongoing pressures. The stock’s recent performance highlights persistent challenges as it continues to trade well below key moving averages and underperforms its sector and benchmark indices.
Read full news article
Decipher Labs Ltd Stock Falls to 52-Week Low of Rs.7.21
2026-02-26 12:41:50Decipher Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.7.21 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning.
Read full news article
Decipher Labs Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-02-24 13:41:05Decipher Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.25 today, marking a significant downturn in its stock performance amid broader market pressures and company-specific financial strains.
Read full news articleAre Decipher Labs Ltd latest results good or bad?
2026-02-13 20:00:56Decipher Labs Ltd's latest financial results reveal significant operational challenges and a troubling trajectory. In Q2 FY26, the company reported net sales of ₹4.31 crores, which reflects a year-on-year decline of 26.58% and a half-yearly performance of ₹7.23 crores, down 38.00% from the previous year. Although there was a sequential improvement in revenue from ₹2.92 crores in Q1 FY26, the overall sales remain substantially below historical levels. The net profit for Q2 FY26 was ₹0.02 crores, translating to a minimal profit margin of 0.46%. This is a stark contrast to the consolidated loss of ₹3.41 crores recorded in H1 FY26, indicating a significant deterioration from a profit of ₹0.62 crores in the same period last year. The operating margin showed a recovery to 2.78% from deeply negative figures in previous quarters, but this improvement appears largely driven by cost-cutting measures rather than genu...
Read full news article
Decipher Labs Q2 FY26: Marginal Recovery Masks Deeper Structural Challenges
2026-02-12 20:21:29Decipher Labs Ltd. (formerly Combat Drugs Ltd.), a micro-cap pharmaceutical company with a market capitalisation of ₹8.00 crores, posted a nominal net profit of ₹0.02 crores in Q2 FY26, marking a technical return to profitability after consecutive quarters of losses. However, this marginal recovery masks deeper structural challenges, with the company's net profit plunging 101.50% year-on-year from ₹1.33 crores in Q2 FY25, whilst revenue contracted 26.58% to ₹4.31 crores. The stock has reacted negatively to the persistent deterioration, declining 36.13% over the past year and trading 41.96% below its 52-week high of ₹14.80, reflecting investor concerns about the sustainability of the business model.
Read full news articleAre Decipher Labs Ltd latest results good or bad?
2026-02-12 19:48:56Decipher Labs Ltd's latest financial results for Q2 FY26 reflect significant operational challenges and a complex financial landscape. The company reported a net profit of ₹0.02 crores, which, while indicating a return to profitability compared to the previous year's loss of ₹1.33 crores, represents a substantial decline of 101.50% year-on-year from the prior profit. This highlights a severe deterioration in earnings quality. Revenue for the quarter was ₹4.31 crores, marking a decline of 26.58% from ₹5.87 crores in the same quarter last year. However, there was a sequential improvement of 47.60% from the previous quarter's revenue of ₹2.92 crores, suggesting some stabilization, albeit from a low base. The operating margin stood at 2.78%, a technical improvement from the deeply negative margins experienced in the previous quarters, yet still far below historical performance levels. The company's return on ...
Read full news articleWhen is the next results date for Decipher Labs Ltd?
2026-02-10 23:17:29The next results date for Decipher Labs Ltd is scheduled for 12 February 2026....
Read full news article
Decipher Labs Ltd Stock Falls to 52-Week Low of Rs.7.8 Amid Continued Weakness
2026-01-27 11:09:24Decipher Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.8 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and broader indices, reflecting persistent challenges in its financial and operational metrics.
Read full news articleShareholder Meeting / Postal Ballot-Scrutinizers Report
12-Feb-2026 | Source : BSEScrutinizers Report for the Extra-ordinary General meeting held on 12.02.2026.
Board Meeting Outcome for Outcome For Board Meeting Held On 12.02.2026
12-Feb-2026 | Source : BSEOutcome of Board Meeting held on Thursday 12th February 2026.
Shareholder Meeting / Postal Ballot-Outcome of EGM
12-Feb-2026 | Source : BSEOutcome of the Extra-ordinary General Meeting held on 12.02.2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






